ANTAGONISTAS DO RECEPTOR CANABINÓIDE CB1 PARA UTILIZAÇÃO NO TRATAMENTO DE DOENÇAS ASSOCIADAS A ANOMALIAS DENDRÍTICAS NEURONAIS

• 收藏
• 分享

专利权人:

UNIVERSITAT POMPEU-FABRA

发明人:

申请号：

PT13710850

公开号：

PT2976074T

申请日:

2013.03.19

申请国别(地区):

PT

年份:

2020

代理人:

摘要：

The invention relates to antagonists of the cannabinoid receptor CBI for use in the treatment and prevention of diseases associated with neural dendritic abnormalities, such as Down's syndrome, Angelman's syndrome, Rett syndrome and tuberous sclerosis. More specifically, the invention provides a method of treatment or prevention of such diseases by the administration of the compound rimonabant.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/